Skip to content

Clinical trials

Withdrawn Phase 1/2 Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20131
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celularity Incorporated1
Darell Bigner1
Endeavor Health1
Fox Chase Cancer Center1
Hadassah Medical Organization1
M.D. Anderson Cancer Center1
Oblato, Inc.1
University of Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma8
Brain Neoplasms4
Glioma4
Astrocytoma2
Gliosarcoma2
Oligodendroglioma2
Central Nervous System Neoplasms1
Neoplasm Metastasis1
Neoplasms1
Neuroblastoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.